Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-14-001344
Filing Date
2014-01-08
Accepted
2014-01-08 16:55:30
Documents
2
Period of Report
2014-01-01

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 17571
2 poaab13.htm EX-24 2967
  Complete submission text file 0001225208-14-001344.txt   21925
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Issuer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PFIZER INC. ATTN CORP. SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017
Business Address
BOURLA ALBERT (Reporting) CIK: 0001595703 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-03619 | Film No.: 14516933